OBJECTIVE
To evaluate the incidence, risk factors, and clinical outcomes associated with venous thromboembolism (VTE) in patients with gynecologic cancer treated with immune checkpoint inhibitors (ICI).
METHODS
This retrospective cohort study included patients with gynecologic malignancies treated with ICI at a singl...
Cassidy Abdeen, Jessica Sciuva, Reed M. O'Connor et al.· Gynecologic Oncology· 0 citations
In this cohort of CC patients treated with IO, approximately 39% and 55% of patients were categorized as high risk according to pre-treatment NRI and PNI, respectively, and high-risk PNI and NRI classifications were associated with differences in irAEs, IO response, and oncologic outcomes.
Julia Chalif, Molly A. Morton, Eric M. McLaughlin et al.· Gynecologic Oncology Reports· 0 citations
Delayed diagnosis of vulvar SCC was associated primarily with provider and healthcare system-related factors rather than patient or tumor characteristics, which may help facilitate more prompt diagnosis and therapeutic intervention.
Julia C. Sakach, Molly A. Morton, Jessica Velasquez et al.· Gynecologic Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.